Sectors
BRTX
BioRestorative Therapies, Inc.
0.21
1 x 0.21
3 x 0.23
bid
ask
+
0.01
4.48%
20 @ 04:00 PM
0.21 +0.00 (2.05%)
| Ytd | -82.05% | |
| 1y | -85.11% |
0.21
day range
0.22
0.16
52 week range
1.89
| Open | 0.21 | Prev Close | 0.20 | Low | 0.21 | High | 0.22 | Mkt Cap | 5.35M |
| Vol | 314.81K | Avg Vol | 10.20M | EPS | -1.19 | P/E | -0.18 | Forward P/E | -0.90 |
| Beta | 0.79 | Short Ratio | 1.95 | Inst. Own | 13.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.34 | 200-d Avg | 0.64 | 1yr Est | 13.00 |
| Income Statement | |||
| Total Revenue | 23.17K | ||
| Revenues (USD) | 23.17K | ||
| Cost of Revenue | 7.39K | ||
| Gross Profit | 15.79K | ||
| Operating Expenses | 3.40M | ||
| Research and Development Expense | 1.93M | ||
| Selling, General and Administrative Expense | 1.48M | ||
| Operating Income | -3.39M | ||
| Net Income | -2.15M | ||
| Net Income Common Stock | -2.15M | ||
| Net Income Common Stock (USD) | -2.15M | ||
| Consolidated Income | -2.15M | ||
| Earnings per Basic Share | -0.12 | ||
| Earnings per Basic Share (USD) | -0.12 | ||
| Earnings per Diluted Share | -0.12 | ||
| Earning Before Interest & Taxes (EBIT) | -2.15M | ||
| Earning Before Interest & Taxes (USD) | -2.15M | ||
| Weighted Average Shares | 17.73M | ||
| Weighted Average Shares Diluted | 17.73M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.11M | ||
| Cash and Equivalents (USD) | 3.11M | ||
| Investments | 479.35K | ||
| Investments Current | 479.35K | ||
| Trade and Non-Trade Receivables | 13.30K | ||
| Current Assets | 3.80M | ||
| Property, Plant & Equipment Net | 328.81K | ||
| Total Assets | 4.64M | ||
| Current Liabilities | 1.61M | ||
| Total Liabilities | 1.61M | ||
| Accumulated Retained Earnings (Deficit) | -172.08M | ||
| Shareholders Equity | 3.03M | ||
| Shareholders Equity (USD) | 3.03M | ||
| Assets Non-Current | 840.57K | ||
| Goodwill and Intangible Assets | 511.76K | ||
| Trade and Non-Trade Payables | 666.90K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 52.39K | ||
| Net Cash Flow from Financing | 4.44M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.60M | ||
| Issuance (Purchase) of Equity Shares | 5.00M | ||
| Net Cash Flow from Investing | 968.45K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 968.45K | ||
| Net Cash Flow from Operations | -3.81M | ||
| Share Based Compensation | 290.21K | ||